Using Oligos Printed on Demand with Enzymatic DNA Synthesis Accelerates Mutagenesis Workflow

This webinar provides an overview of enzymatic DNA synthesis (EDS) and the core technology behind the SYNTAX System, the world’s first benchtop enzymatic DNA printer. The Pasteur Institute, an early adopter of the SYNTAX System, has leveraged EDS oligos for a variety of applications including rRNA depletion, COVID-19 research, and mutagenesis studies. As an example of how oligos on demand can accelerate innovation, the Pasteur Institute's Dr. Colin Clairet describes his current project involving mutant construction of the rising fungal pathogen Candida glabrata using SYNTAX oligos.